²é¿´: 2132  |  »Ø¸´: 41
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û25´Î£¬×÷Õßluai071Ôö¼Ó½ð±Ò 18.5 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

luai071

ľ³æ (ÖøÃûдÊÖ)


[×ÊÔ´] µÚÈý½ì¹ú¼ÊÀíÂÛ»¯Ñ§¡¢·Ö×ÓÄ£ÄâºÍÉúÃü¿ÆÑ§ÑÐÌÖ»áÂÛÎļ¯--»¯Ñ§¼°·Ö×ÓÄ£Äⲿ·Ö

µÚÈý½ì¹ú¼ÊÀíÂÛ»¯Ñ§¡¢·Ö×ÓÄ£ÄâºÍÉúÃü¿ÆÑ§ÑÐÌÖ»áôßµÚÈý½ì±±¾©ºê½£¹«Ë¾Óû§´ó»áÂÛÎº

Ö÷½²µÄѧÕß¶¼ÊÇÒµÄڵľ«Ó¢£¬ÄÚÈÝÊ®·Ö¾«²Ê¡£²»¶à˵ÁË£¬´ó¼ÒÏÂÔØ°É¡£¶ÔÁË£¬±ðÍü¸øÔÚÏÂÒ»µã¹ÄÀø£¬Ð»Ð»£¡

Óгæ×Ó˵Ãû×ÖºÍÄÚÈݲ»·û£¬ÆäʵÕâ´Î´ó»áÉϵĻ¯Ñ§ºÍ·Ö×ÓÄ£Äⲿ·Ö¶¼ºÍÉúÃüÉúÃü¿ÆÑ§Óйأ¬¶øÇÒ±¾½ì´ó»áµÄÖ÷°ìµ¥Î»Ö®Ò»£ººê½£¹«Ë¾¾ÍÊÇ´úÀíÍâ¹úµÄÒ©ÎïÉè¼ÆÈí¼þµÄ£»´ËÍâÎÒÕâÀﻹÓвÄÁÏ¿ÆÑ§²¿·Ö£¬ÒѾ­·¢µ½²ÄÁϰæÁË¡£

[ Last edited by luai071 on 2007-11-1 at 12:15 ]
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ls.hb.xw


ºÇºÇ£¬²»´í°¡£¬Ð»Ð»
6Â¥2007-10-30 18:30:34
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 42 ¸ö»Ø´ð

luai071

ľ³æ (ÖøÃûдÊÖ)


ÉúÃü¿ÆÑ§Æª
Theoretical Study of the Vertical Excited States of Benzene, Pyrimidine, and Pyrazine by the Symmetry A
dapted Cluster¡ªConfiguration Interaction Method¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.¡­¡­¡­¡­¡­¡­¡­¡­¡­...P311
Molecular Docking and Three-Dimensional Quantitative Structure-Activity Relationship Studies on the
Binding Modes of Herbicidal 1-(Substituted Phenoxyacetoxy)alkylphosphonates to the E1 Component of
Pyruvate Dehydrogenase¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.¡­¡­¡­¡­¡­¡­¡­¡­¡­P321
A Time-Dependent Density Functional Theory Investigation of the Spectroscopic Properties of the ¦Â -Subunit
In C-Phycocyanin¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.¡­¡­¡­¡­¡­¡­¡­¡­¡­.P331
Structures and properties of cytosine¨CBX3 (XZF, Cl) complexes: an investigation with DFT and MP2 methods
¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P336
Similarity Networks of Protein Binding Sites¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P346
Empirical Correction to Molecular Interaction Energies in Density Functional Theory (DFT) for Methane
Hydrate Simulation¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P355
Potential of Eigen Value Method to the Study on Structure-antioxidant Activity Relationship¡­¡­¡­¡­¡­¡­¡­..P363
CoMFA 3D-QSAR Analysis of Epothilones Based on Docking Conformation and Alignment¡­¡­¡­¡­¡­¡­¡­.P370
HIV µ°°×øÒÖÖÆ¼Á¡ª¡ªÀûµÏÁ´¾úËØµÄ·Ö×Ó¶Ô½ÓÑо¿¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...P378
3D-QSAR studies on glycogen phosphorylase inhibitors by flexible comparative molecular field analysis..........P383
µÚ 3 Ò³
Complex-type-dependent scoring functions in protein¨Cprotein docking¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­P389
High-throughput real-time assay based on molecular beacons for HIV-1 integrase 3'-processing reaction............P400
Prediction of the binding mode between BMS-378806 and HIV-1 gp120 by docking and molecular dynamics
simulation¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P407
Analysis of Domain Movements in Glutamine-Binding Protein with Simple Models¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­P414
Peptide Reagent Design Based on Physical and Chemical Properties of Amino Acid Residues¡­¡­¡­¡­¡­¡­¡­.P424
Multiple Field Three Dimensional Quantitative Structure¨CActivity Relationship (MF-3D-QSAR)¡­¡­¡­¡­¡­..P432
Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of
neuraminidases¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P443
Predicting the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino
acid-based peptide prediction¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...P450
Prediction of Distribution of Neutral, Acidic and Basic Structurally Diverse Compounds Between Blood and
Brain by the Nonlinear Methodology¡­.¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P457
Theoretical studies on the formation of N-nitrosodimethylamine¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­P485
Conformers and Properties of Proline¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...P491
3D-QSAR studies on tripeptide aldehyde inhibitors of proteasome using CoMFA and CoMSIA methods¡­¡­¡­P498
Quantum and Molecular Dynamics Study for Binding of Macrocyclic Inhibitors to Human a-Thrombin.¡­¡­¡­P512
Evaluation of FlexX, GOLD and LigandFit on Their Docking Performance Using a Diverse Test Set Derived
from the PDBbind Database¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.................P513
Physics-based Scoring Method in Drug Discovery¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..........P515
ϸ°ûÄÚ¸ÆÀë×ÓÕñµ´ÌåϵÖеÄËæ»úЧӦ¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P517
µ°°×ÖÊ´¿»¯·ÂÉúÇ׺ÍÅäÌåÑо¿¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...¡­...P519
ǿְ©ÐÔN-ÑÇÏõ°·ÐγɻúÀí¼°¹ýÑõÑÇÏõËá¸ù¶¾ÐÔ»úÀíµÄÑо¿¡­...¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P520
ÖйúÉúÎï¼¼ÊõÖÆÒ©ÓëÅ·ÃÀ¹ú¼ÒµÄ±È½Ï. ¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..¡­¡­¡­¡­..P521
Comparison of Biophamaseutics among USA, EU and China¡­¡­¡­¡­...¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.P526
Study on QSSR with the atomic ionicity indices¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­.¡­¡­¡­¡­..¡­¡­¡­..P527
Study of molecular docking of mu opioid receptor agonist---fentanyl and its analogs based on Surflex-Docking
¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..P537
Mu °¢Æ¬ÊÜÌåµÄÈýά½á¹¹Ä£½¨¼°»îÐÔλµã·ÖÎö¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..........P547
ÒÔG-ËÄÁ´ÌåΪ°Ð±êµÄ¿¹Ö×ÁöÒ©ÎïÐéÄâɸѡ¡¢·Ö×Ó»úÀí¼°ÉúÎï»îÐÔÑо¿¡­¡­¡­¡­...¡­¡­¡­¡­..¡­¡­¡­¡­...P552
Studies on virtual screening, molecular mechanism and bioactivity of anti-cancer drug targeting G-quadruplex
¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...¡­¡­¡­¡­¡­¡­¡­...P553
»ùÓÚDNA °Ð·Ö×Óʶ±ðµÄ¿¹Ö×ÁöÒ©ÎïµÄÉè¼Æ¡¢·Ö×Ó»úÀí¼°ÉúÎï»îÐÔÑо¿¡­¡­¡­¡­¡­¡­¡­¡­...¡­¡­¡­¡­...P554
Comparative Evaluation of 15 Scoring Functions on PDBbind Core Set of 210 Protein-Ligand Complexes¡­¡­P555
Evaluation of MM/PBSA method on NMR structures¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..¡­¡­¡­¡­¡­..P557
Pharmacophore screening with piperdinecarboxamides derivatives using GALAHAD study and CoMFA study
based on these pharmacophores¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­...........P559
ÐÂÑ̼îÀàɱ³æ¼Á¼°Ïà¹Ø»¯ºÏÎï½á¹¹Óë»îÐÔ¹ØÏµµÄCoMFA ¼°CoMSIA Ñо¿¡­¡­¡­¡­¡­¡­¡­¡­¡­............P571
Ò©ÎïÐéÄâɸѡµÄ³É¹¦Óë²»×ã¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­..............P583
Design, Synthesis and Preliminary Activity Assay in vitro of L-lysine Derivatives as APN Inhibitors¡­¡­¡­¡­.P584
A molecular dynamics and QM/MM study on the acetylating inactivation of isoniazid¡­¡­¡­¡­¡­¡­.¡­...........P585
Conformation-Based Design of Camptothecin Analogues as Potent DNA Topoisomerase I inhibitors¡­............P586
Multiscale modelling and simulation of biological systems¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­............P587
Models for binding cooperativities of inhibitors with transthyretin¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­............P589
Three-dimensional common-feature hypotheses for fentanyl derivatives¡­¡­¡­¡­...¡­¡­¡­¡­¡­¡­¡­.¡­¡­¡­...P602
µÚ 4 Ò³
2Â¥2007-10-30 16:52:51
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

luai071

ľ³æ (ÖøÃûдÊÖ)


´óС ÎļþÃû
21.7M  Papers--Bio.pdf

  
ÒѾ­³É¹¦µØ±£´æÔÚMofile  
ÎļþÌáÈ¡Â룺 0644639448462145
  
    µ±ÄúµÄÅóÓÑÐèÒªÌáÈ¡´ËÎļþʱֻÐè:
     ÄäÃûÌáÈ¡ÎļþÁ¬½Ó http://pickup.mofile.com/0644639448462145  
     »òµÇ¼Mofile£¬Ê¹ÓÃÌáÈ¡Âë 0644639448462145 ÌáÈ¡Îļþ

[ Last edited by luai071 on 2007-10-30 at 18:10 ]
3Â¥2007-10-30 17:10:41
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

luai071

ľ³æ (ÖøÃûдÊÖ)


´óС ÎļþÃû
21.7M  Papers--Bio.pdf

  
ÒѾ­³É¹¦µØ±£´æÔÚMofile  
ÎļþÌáÈ¡Â룺 0644639448462145
  
    µ±ÄúµÄÅóÓÑÐèÒªÌáÈ¡´ËÎļþʱֻÐè:
     ÄäÃûÌáÈ¡ÎļþÁ¬½Ó http://pickup.mofile.com/0644639448462145  
     »òµÇ¼Mofile£¬Ê¹ÓÃÌáÈ¡Âë 0644639448462145 ÌáÈ¡Îļþ


4Â¥2007-10-30 17:22:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 286Çóµ÷¼Á +4 Faune 2026-03-21 4/200 2026-03-21 13:22 by zhukairuo
[¿¼ÑÐ] Çóµ÷¼Á +3 °×QF 2026-03-21 3/150 2026-03-21 13:12 by zhukairuo
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖпƼ¼´óѧ071000£¬Çóµ÷¼Á +3 ÑØ°¶Óб´¿Ç6 2026-03-21 3/150 2026-03-21 10:35 by ÄºÔÆÇ庮
[¿¼ÑÐ] 085601µ÷¼Á 358·Ö +3 zzzzggh 2026-03-20 4/200 2026-03-21 10:21 by luoyongfeng
[¿¼ÑÐ] Çóµ÷¼Á +6 Mqqqqqq 2026-03-19 6/300 2026-03-21 08:04 by JourneyLucky
[¿¼ÑÐ] Äϲý´óѧ²ÄÁÏר˶311·ÖÇóµ÷¼Á +6 77chaselx 2026-03-20 6/300 2026-03-21 07:24 by JourneyLucky
[¿¼ÑÐ] һ־Ըɽ´ó07»¯Ñ§ 332·Ö ËÄÁù¼¶Òѹý ±¾¿ÆÉ½¶«Ë«·Ç Çóµ÷¼Á£¡ +3 ²»ÏëÀíÄã 2026-03-16 3/150 2026-03-21 03:59 by JourneyLucky
[¿¼ÑÐ] ²ÄÁϹ¤³Ì£¨×¨£©Ò»Ö¾Ô¸985 ³õÊÔ335Çóµ÷¼Á +3 hiloiy 2026-03-17 4/200 2026-03-21 03:04 by JourneyLucky
[¿¼ÑÐ] 083200ѧ˶321·ÖÒ»Ö¾Ô¸ôßÄÏ´óѧÇóµ÷¼Á +3 innocenceF 2026-03-17 3/150 2026-03-21 02:35 by JourneyLucky
[¿¼ÑÐ] 265Çóµ÷¼Á +9 ÁºÁºÐ£Ð£ 2026-03-17 9/450 2026-03-21 02:17 by JourneyLucky
[¿¼ÑÐ] 295Çóµ÷¼Á +4 Ò»Ö¾Ô¸¾©Çø211 2026-03-18 6/300 2026-03-20 23:41 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ£¬327·Ö£¬²ÄÁÏÓ뻯¹¤085600 +9 Ncdx123456 2026-03-19 9/450 2026-03-20 23:41 by lovewei0727
[¿¼ÑÐ] 294Çóµ÷¼Á²ÄÁÏÓ뻯¹¤×¨Ë¶ +15 ݤÎÉ­ÁÖ 2026-03-18 15/750 2026-03-20 23:28 by JourneyLucky
[¿¼ÑÐ] 330Çóµ÷¼Á +4 С²Ä»¯±¾¿Æ 2026-03-18 4/200 2026-03-20 23:13 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸Î人Àí¹¤²ÄÁϹ¤³Ìר˶µ÷¼Á +9 Doleres 2026-03-19 9/450 2026-03-20 22:36 by JourneyLucky
[¿¼ÑÐ] 324Çóµ÷¼Á +5 luckyѽѽѽѼ 2026-03-20 5/250 2026-03-20 22:30 by ´ÙÌì³É
[ÂÛÎÄͶ¸å] ÉêÇë»Ø¸åÑÓÆÚÒ»¸öÔ£¬±à¼­Í¬ÒâÁË¡£µ«ÏµÍ³ÉϵÄʱ¼äû±ä£¬¸ø±à¼­ÓÖдÓʼþÁË£¬Ã»»Ø¸´ 10+3 wangf9518 2026-03-17 4/200 2026-03-19 23:55 by babero
[¿¼ÑÐ] 344Çóµ÷¼Á +6 knight344 2026-03-16 7/350 2026-03-18 20:13 by walc
[¿¼ÑÐ] 334Çóµ÷¼Á +3 Ö¾´æ¸ßÔ¶ÒâÔÚ»úÐ 2026-03-16 3/150 2026-03-18 08:34 by lm4875102
[¿¼ÑÐ] »úеר˶325£¬Ñ°ÕÒµ÷¼ÁԺУ +3 y9999 2026-03-15 5/250 2026-03-16 19:58 by y9999
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û